Personalis at European NeoAG Summit 2019: April 24-25
Presentation
Wednesday, APR 24 | 2:30 PM CEST
Sean Michael Boyle, PhD
Director, Bioinformatics Applications
Personalis, Inc.
ImmunoID NeXT Platform: Improving Neoantigen Prediction, TME Assessment, and ctDNA Detection for Vaccine Development
- Innovative genomics methods for more comprehensive assessment of neoantigens
- Improving neoantigen to MHC binding prediction and ranking
- Assessing TME/TCR and tumor escape mechanisms that may impact vaccine response